1. Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon‐a2a/ribavirin in combination with a direct‐acting anti‐viral – authors' reply. Issue 5 (13th August 2013) Authors: Ferenci, P.; Rutter, K. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 5(2013) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis?. Issue 11 (December 2013) Authors: Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 11/12(2013) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durability of SVR in chronic hepatitis C patients treated with peginterferon‐α2a/ribavirin in combination with a direct‐acting anti‐viral. Issue 2 (26th May 2013) Authors: Rutter, K.; Hofer, H.; Beinhardt, S.; Dulic, M.; Gschwantler, M.; Maieron, A.; Laferl, H.; Stättermayer, A. F.; Scherzer, T.‐M.; Strassl, R.; Holzmann, H.; Steindl‐Munda, P.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 2(2013) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon‐free direct‐acting antiviral combinations?. Issue 6 (15th February 2018) Authors: Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 6(2018) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Excellent long-term virological and clinical response in HDV compensated cirrhotics treated with high dose Bulevirtide beyond 2.5 years: A case series. (March 2021) Authors: Loglio, A.; Ferenci, P.; Renteria, SC. Uceda; Holzmann, H.; Borghi, M.; Perbellini, R.; Rimondi, A.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Prati, D.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension. Issue 4 (29th June 2018) Authors: Mandorfer, M.; Scheiner, B.; Stättermayer, A. F.; Schwabl, P.; Paternostro, R.; Bauer, D.; Schaefer, B.; Zoller, H.; Peck‐Radosavljevic, M.; Trauner, M.; Reiberger, T.; Ferenci, P.; Ferlitsch, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 4(2018) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses. Issue 6 (16th July 2015) Authors: Mandorfer, M.; Kozbial, K.; Freissmuth, C.; Schwabl, P.; Stättermayer, A. F.; Reiberger, T.; Beinhardt, S.; Schwarzer, R.; Trauner, M.; Ferlitsch, A.; Hofer, H.; Peck‐Radosavljevic, M.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 6(2015) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti‐HCV therapy? – authors' reply. Issue 4 (February 2016) Authors: Mandorfer, M.; Kozbial, K.; Peck‐Radosavljevic, M.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 4(2016) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter: comparing scoring systems and outcome of patients admitted to a liver intensive care unit with severe variceal bleeding. Issue 7 (October 2014) Authors: Payer, B. A.; Ferenci, P.; Zauner, C. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 7(2014) Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Letter: does the IFNL4 gene discovery really provide a causal role for the IL28B haplotype blocks? Authors' reply. Issue 5 (4th February 2014) Authors: Stättermayer, A. F.; Ferenci, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 5(2014) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗